Q1 FY27 Earnings: Margin Squeeze Hits FMCG & Auto

Q1 FY27 Earnings Reveal a Margin Problem That Won't Disappear Quietly Q1 FY27 earnings season is delivering an uncomfortable message: revenue is growing, but profits aren't keeping pace. Across Nifty 50 manufacturing and consumer names, operating expenses are outrunning topline growth at a rate not seen since FY21. The cumulative H1 EBITDA margin for the index's consumer and industrial cohort has slipped to its worst reading in six years, according to aggregated Bloomberg consensus data. That's not a one-quarter blip. It's a structural cost problem that investors need to price in now. The proximate cause is a simultaneous rise in several raw material categories. Palm oil, crude derivatives, packaging polymers, and steel all moved higher in the April–June period, squeezing companies that locked in pricing before input costs inflated. Companies that passed costs through to consumers last year are finding that consumer resistance in rural markets is real. Volume growth is stalling just as cost bases expand. That combination is toxic for operating margins. The market reaction has been stock-specific but broadly negative. Stocks entering earnings with FairStock Scores below 55 have seen average post-result declines of 4–7% in intraday sessions. Names with stronger scores above 68 have held better, but even they aren't immune when guidance gets cut. FMCG Stocks Face the Sharpest Margin Compression [Hindustan Unilever](/stock/HINDUNILVR) (NSE: HINDUNILVR) is the bellwether here. The company's gross margins have been tracking 150–200 basis points below year-ago levels, with palm oil and crude-linked packaging costs the primary culprits. Management has been cautious on volume recovery timelines in rural segments. At a trailing P/E near 55x, the stock prices in a lot of execution. Right now, execution is under stress. [Dabur India](/stock/DABUR) (NSE: DABUR) faces similar pressure. Its ayurvedic and healthcare product mix relies heavily on herb-based inputs whose prices...